Some of the stories that caught my attention:

• Vietnam veterans exposed to Agent Orange have an increased risk of developing multiple myeloma, a new study suggests.
• The FDA approved Varubi (rolapitant), a drug to prevent chemotherapy induced nausea and vomiting. The drug was approved after three phase 3 clinical trials involving 2800 adults.
• A recent study published in JAMA Surgery shows a rise in double mastectomy among males. While male breast cancer cases are less common than women, men are less likely to survive the disease. Results analyzed in this paper, revealed that during a seven year period, double mastectomies for men went from 3% in 2004 to 5.6% in 2011.
• The American Society of Clinical Oncology (ASCO) released new guidelines on genetic and genomic testing. The guidelines were published online in the Journal of Clinical Oncology and are available on the ASCO website.